| Description |
| Product Type |
Product Size |
| Tablet |
20'S |
| Product Company |
| Getz Pharma |
Febuxostat 40mg |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Himmel Pharma
|
Carboplatin 150mg/15ml |
| Product Type |
Product Size |
| Tablet |
30'S |
| Product Company |
| Sanofi |
Furosemide and amiloride 5mg |
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Sandoz |
|
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Fresenius kabi |
Cytarabine 500mg/50ml |
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
AJM Pharmaceuticals |
|
| Content | Febuxostat is in a class of medications called xanthine oxidase inhibitors. It works by decreasing the amount of uric acid that is made in the body. Febuxostat is used to prevent gout attacks but not to treat them once they occur.
| Carboplatin is an alkylating agent used to treat advanced ovarian cancer.Carboplatin is indicated in combination with an established combination of chemotherapeutic agents for the initial treatment of advanced ovarian carcinoma. Carboplatin is also indicated for the palliative treatment of ovarian carcinoma, recurrent after prior chemotherapy.
| A combination of Furosemide and Amiloride is a diuretic which reduces the potassium loss of furosemide alone while avoiding the possible gastro-intestinal disturbances of potassium supplements.
| Gemcitabine is a cytidine analog with two fluorine atoms.As a prodrug, gemcitabine is transformed into its active metabolites that work by replacing the building blocks of nucleic acids during DNA elongation, arresting tumour growth and promoting apoptosis of malignant cells. | Cytarabine is a medication used in the management and treatment of leukemias and lymphomas. It belongs to the antimetabolic group of medications. This activity reviews the indications, action, and contraindications for cytarabine as a valuable agent in treating acute myeloid leukemia (and other leukemias. | Gemcitabine is a nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer. |
Reviews
There are no reviews yet.